Abstract
Quinine, the oldest universally known antimalarial agent, has been the subject of numerous reviews in the past. We do not intend in this chapter to repeat once more all the known facts about quinine, but rather to select and critically discuss those properties which are essential for an assessment of its merits and its defaults in comparison with its modern successors. Since only those properties will be mentioned which contribute to an appraisal and understanding of the antimalarial activity, the therapy of cardiac arrhythmias for which quinidine is one of today’s standard drugs will not be dealt with (for a review on antiarrhythmic drugs see Bigger and Hofman 1980).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Anonymous (1973) Drug-induced deafness. JAMA 224:515–516
Anonymous (1980) Epidemiologic notes and reports:Plasmodium falciparum malaria contracted in Thailand resistant to chloroquine and sulphonamide-pyrimethamine. Morbidity and Mortality Weekly Report 29:493–495
Bankes JLK, Hayward JA, Jones MBS (1972) Quinine amblyopia treated with stellate ganglion block. Br Med J 4:85–86
Barrow SE, Taylor AA, Horning EC, Horning MG (1980) High-performance liquid chromatographic separation and isolation of quinidine and quinine metabolites in rat urine. J Chromatogr 181:219–226
Beermann B, Leander K, Lindström B (1976) The metabolism of quinidine in man:structure of the main metabolite. Acta Chem Scand [B] 30:465
Beutler E (1972) Drug-induced anemia. Fed Proc 31:141–146
Bigger JT, Hoffmann BF (1980) Antiarrhythmic drugs. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, pp 761–792
Brodie BB, Udenfriend S (1943) The estimation of quinine in human plasma with a note on the estimation of quinine. J Pharmacol Exp Ther 78:154–158
Brodie BB, Baer JE, Craig LC (1951) Metabolic products of the cinchona alkaloids in human urine. J Biol Chem 188:567–581
Brossi A, Uskokovié M, Gutzwiller J, Krettli AU, Brener Z (1971) Antimalarial activity of natural, racemic and unnatural dihydroquinine, dihydroquinidine and their various racemic analogs in mice infected with Plasmodium berghei. Experientia 27:1100–1101
Brossi A, Uskokovié M, Gutzwiller J, Krettli AU, Brener Z (1973) Antimalarial activity of racemic 3-epidihydroquinine, 3-epidihydroquinidine and their various racemic analogs in mice infected with Plasmodium berghei. Experientia 29:367–368
Brotherton J (1978) Biological assay of potential trichomonacides in vitro using a counter apparatus. Arzneimittelforsch 28:1665–1672
Caroll FI, Smith D, Wall ME, Moreland CG (1974) Carbon-13 magnetic resonance study. Structure of the metabolites of orally administered quinidine in humans. J Med Chem 17:985–987
Carroll FI, Philip A, Coleman MC (1976) Synthesis and stereochemistry of a metabolite re-sulting from the biotransformation of quinidine in man. Tet Lett (21):1757–1760
Carter G, van Dyke K (1972) Drug effects on phosphorylation of adenosine and its incor-poration into nucleic acids of chloroquine sensitive and resistant erythrocyte-free malar-ia parasite. J Parasitol (Special Issue) 39:244–249
Chongsuphajaisiddhi T, Subchareon A, Puangpartk S, Harinasuta T (1979) Treatment of falciparum malaria in Thai children. Southeast Asian J Trop Med Public Health 10:132–137
Chou AC, Chevli R, Fitch CD (1980) Ferriprotoporphyrin IX fulfills the criteria for iden-tification as the chloroquine receptors of malaria parasites. Biochemistry 19:1543–1549 Colwell EJ, Hickman RL, Kosakal S (1972) Tetracycline treatment of chloroquine-resistant falciparum malaria in Thailand. JAMA 220:684–686
Conrad KA, Molk BL, Chidsey CA (1977) Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation 55:1–7
Corby C, Dunnett N, Kimber KJ, Walls HJ (1964) Acute fatal quinine poisoning. In: Forensic immunology, medicine, pathology and toxicology (Proc 3rd Internat Meeting, London, April 16–24, 1963 ). Excerpta Medica Foundation, London, pp 118–119
Cramer G, Isaksson B (1973) Quantitative determination of quinidine in plasma. Scand J Clin Lab Invest 15:553–556
Davies EE, Warhurst DC, Peters W (1975) The chemotherapy of rodent malaria, XXI. Action of quinine and WR 122455 (a 9-phenanthrenemethanol) on the fine structure of Plasmodium berghei in mouse blood. Ann Trop Med Parasitol 69:147–153
Davidson MW, Griggs BG, Boykin DW, Wilson WD (1977) Molecular-structural effects involved in the interaction of quinolinemethanolamines with DNA. Implications for antimalarial action. J Med Chem 20:1117–1122
Deichman WB, Gerarde HW (1969) Toxicology of drugs and chemicals. Academic, New York, p 511
Drayer DE, Cook CE, Reidenberg MM (1976) Active quinidine metabolites. Clin Res 24:623A
Drayer DE, Lowenthal DT, Restivo KM, Schwartz A, Cook CE, Reidenberg MM (1978) Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degree of renal function. Clin Pharmacol Ther 24:31–39
Einheber A, Palmer DM, Aikawa M (1976) Plasmodium berghei:Phase contrast and electron microscopic evidence that certain antimalarials can both inhibit and reverse pigment clum** caused by chloroquine. Exp Parasitol 40:52–61
Findlay GM (1951) Recent advances in chemotherapy, 3rd edn, vol 2. Churchill J+A, London
Fischl V, Schlossberger H (1934) Handbuch der Chemotherapie. Fischers medizinische Buchhandlung, Leipzig, pp 140–223
Fitch CD (1972) Chloroquine resistance in malaria:drug binding and cross resistance patterns. J Parasitol (Special Issue) 39:265–271
Flaks B (1978) Effects of chronic oral dosing with quinine sulphate in the rat. Pathol Res Pract 163:373–377
Glew RH, Collins WE, Miller LH (1978) Selection of increased quinine resistance in Plasmodium falciparum in Aotus monkeys. Am J Trop Med Hyg 27:9–13
Guentert TW, Coates PE, Upton RA, Combs DL, Riegelman S (1979a) Determination of quinidine and its major metabolites by high-performance liquid chromatography. J Chromatogr 162:59–70
Guentert TW, Upton RA, Holford NHG, Riegelman S (1979b) Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods. J Pharmacokinet Biopharm 7:303–311
Guerra T (1977a) The introduction of cinchona in the treatment of malaria. Part 1. J Trop Med Hyg 80:112–118
Guerra T (1977b) The introduction of cinchona in the treatment of malaria. Part 2. J Trop Med Hyg 80:135–139
Hahn FE (1979) Quinine. In: Hahn FE (ed) Antibiotics, vol V, part 2. Springer, Berlin Heidelberg, New York, pp 353–362
Hall AP (1974) Quinine fever in falciparum malaria. Southeast Asian J Trop Med Public Health 5:413–416
Hall AP, Czerwinski AW, Madonia EC, Evensen KL (1973) Human plasma and urine quinine levels following tablets, capsules, and intravenous infusion. Clin Pharmacol Ther 14:580–585
Hall AP, Doberstyn EB, Nanakorn A, Sonkom P (1975a) Falciparum malaria semi-resistant to clindamycin. Br Med J 1975:12–14
Hall AP, Doberstyn EB, Mettaprakong V, Sonkom P (1975b) Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine. Br Med J 1975:15–17
Hall AP, Doberstyn EB, Karnchanachetanee C, Samransamruajkit S, Laixuthai B, Pearlman E, Lampe RM, Miller CF, Phintuyothin P (1977) Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Br Med J 1:1626–1628
Hawkins JE Jr (1976) In: Keidel WD, Neff WD (eds) Clinical and special topics. Springer, New York Berlin Heidelberg, pp 707–748 (Handbook of sensory physiology, vol V/3)
Haznagy A (1976) Beitrag zur Bestimmung des Gesamtalkaloidgehaltes von Cortex Chinae. Pharmazie 31:713–715
Hiatt EP, Quinn GP (1945) The distribution of quinine, quinidine, cinchonine and cinchonidine in fluids and tissues of dogs. J Pharmacol Exp Ther 83:101–105
Hill J (1950) The schizonticidal effect of some antimalarials against Plasmodium berghei. Ann Trop Med Parasitol 44:291–297
Hill J (1963) Chemotherapy of malaria. Part 2. Antimalarial drugs. In: Schnitzer AJ, Hawking F (eds) Experimental chemotherapy, vol I. Academic, New York, pp 514–524
Hommel M, McColm AA, Trigg PI (1979) Plasmodium knowlesi: inhibition of invasion by pretreatment of erythrocytes with chloroquine and quinine. Ann Microbiol (Paris) 130(B):287–293
Hybels RL (1979) Drug toxicity of the inner ear. Med Clin North Am 63:309–319
Jearnpipatkul A, Panijpan B (1980) Molecular complexes of quinoline antimalarials with iron-porphyrin components of protease-digested methemoglobin. Chem-Biol Interact 33:83–90
Jearnpipatkul A, Govitrapong P, Yuthavong Y, Wilairat P, Panijpan B (1980) Binding of antimalarial drugs to hemozoin from Plasmodium berghei. Experientia 36:1063–1064
Jovanovic J, Remberg G, Ende M, Spiteller G (1976) Quinine-N-oxide — urinary component after the consumption of quinine beverages. Arch Toxicol 35:137–139
Karawya MS, Diab AM (1977) Colorimetric assay of quinine and quinidine in raw materials, formulations, and biological fluids. J Pharm Sci 66:1317–1319
Kelsey FE, Oldham FK, Geiling EMK (1943) Studies on antimalarial drugs. The distribu-tion of quinine in the tissues of the fowl. J Pharmacol Exp Ther 78:314–319
Klayman DL, Griffin TS, Bower JD, Page SW (1973) Thiosulfuric acid analog of quinine as a potential antimalarial agent. J Med Chem 16:1042–1043
Laser H, Kemp P, Miller N, Lander D, Klein R (1975) Malaria, quinine, and red cell lysis. Parasitology 71:167–181
Leete E (1969) Biosynthesis of quinine and related alkaloids. Acc Chem Res 2:59–64
Levine LH, Hirsch CS, White LW (1973) Quinine cardiotoxicity:a mechanism for sudden death in narcotic addicts. J Forensic Sci 18:167–172
McVie JG (1979) Antimicrobial drugs. In: Girdwood RH (ed) Clinical pharmacology, 24th edn. Baillière Tindall, London, pp 69–157
Merkli B, Richle R (1980) Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Trop (Basel) 37:228–231
Miller LH, Glew RH, Wyler DJ, Howard WA, Collins WE, Contacos PG, Neva FA (1974) Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum. Am J Trop Med Hyg 23:565–569
Ochs HR, Greenblatt DJ, Woo E (1980) Clinical pharmacokinetics of quinidine. Clin Pharmacokinet 5:150–168
Palmer KH, Martin B, Baggett B, Wall ME (1969) The metabolic fate of orally administered quinidine gluconate in humans. Biochem Pharmacol 18:1845–1860
Pellegrino J, Katz N (1974) Experimental therapeutics on Schistosoma mansoni, IX. Activity of quinine and isomers. Rev Inst Med Trop Sao Paulo 16:301–304
Peters W (1970) Chemotherapy and drug resistance in malaria. Academic, London
Peters W, Portus JH, Robinson BL (1975) The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activ-ity. Ann Trop Med Parasitol 69:155–171
Peters W, Howells RE, Portus J, Robinson BL, Thomas S, Warhurst DC (1977) The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142490). Ann Trop Med Parasitol 71:408–418
Pettit GR, Gupta SK (1968) Structural biochemistry. Part VIII. 9-Amino-9-deoxy-cinchona alkaloids. J Chem Soc (C):1208–1213
Polet H, Barr C (1968) Chloroquine and dihydroquinine. In vitro studies of their antimalarial effect upon Plasmodium knowlesi. J Pharmacol Exp Ther 164:380–386
Pound NJ, Sears RW (1975) HSLC and TLC determination of quinidine and quinine and related alkaloids in pharmaceuticals. Can J Pharm Sci 10:122–126
Rollo IM (1980) Drugs used in the chemotherapy of malaria. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, pp 1038–1060
Saggers VH, Hariratnajothi N, Mc Lean AEM (1969) The effect of diet and phenobarbitone on quinine metabolism in the rat and in man. Biochem Pharmacol 19:499–503
Sainsbury M (1978) Quinoline alkaloids. In: Coffey S (ed) Rodd’s chemistry of carbon com-pounds, 2nd ed, vol IV/G. Elsevier, Amsterdam, pp 225–246
Savini EC, Moulin MA, Herron MFJ (1971) Etude expérimentale des effets de la quinine sur le foetus de rat, de lapin, de chien. Therapie 26:563–574
Savran SV, Flamm MD Jr, Grant D (1975) Fever as a toxic reaction to quinidine. N Engl J Med 292:427
Schmidt LH (1955) Antimalarials. In: Manske RHF (ed) The alkaloids, chemistry and physiology, vol 5. Academic, New York, pp 141–161
Schmidt LH (1978a) Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus) II. Responses to chloroquine, quinine, and pyrimethamine. Am J Trop Med Hyg 27:703–717
Schmidt LH, Crosby R, Rasco J, Vaughan D (1978b) Antimalarial activities of various 4quinoline-methanols with special attention to WR 142,490 (mefloquine). Antimicrob Agents Chemother 13:1011–1030
Schroeder K (1913) Untersuchungen über einige Chininderivate. Arch Exper Path Pharmakol 72:361–386
Sherman JW (1976) The ribosome of the simian malaria Plasmodium knowlesi. V. A cell-free protein synthesizing system. Comp Biochem Physiol [B] 53:447–450
Stoll A, Jucker E (1953) China-Alkaloide. In: Foerst W (ed) Ullmanns Encyklopädie der technischen Chemie, 3rd edn, vol 3, Urban & Schwarzenberg, Munich, pp 210–222
Sucharit P, Suntharasamai P, Chintana T, Harinasuta T (1979) In vivo and in vitro studies of quinine sensitivity of Plasmodium falciparum in Thailand. Southeast Asian J Trop Med Public Health 10:138–141
Sucharit P, Eamsobana P (1980) In vitro response of Plasmodium falciparum in Thailand to antimalarial drugs. Ann Trop Med Parasitol 74:11–15
Sweeney TR, Strube RE (1979) Antimalarials. In: Wolf ME (ed) Burger’s medicinal chemistry, 4th ed, Part II. Wiley, New York, pp 333–413
Thompson PE, Werbel LM (1972) Antimalarial agents. Academic, New York, pp 62–78 Toama MA (1980) In vitro synergism between tetracyclines and antimalarials. Chemotherapy 26:191–195
Trenholme GM, Williams RL, Rieckmann KH, Frischer H, Carson PE (1976) Quinine dis-position during malaria and during induced fever. Clin Pharmacol Ther 19:459–467
Turner RB, Woodward RB (1953) The chemistry of the cinchona alkaloids. In: Manske RHF, Holmes HL (eds) The alkaloids, vol III. Academic, New York, pp 1–63
Ueda CT, Hirschfeld DS, Scheinman MM, Rowland M, Williamson BJ, Dzindzio BS (1976) Disposition kinetics of quinidine. Clin Pharmacol Ther 19:30–36
Uskokovie MR, Grethe G (1973) The Cinchona alkaloids. In: Manske RHF (ed) The alkaloids, vol XIV. Academic, New York, pp 181–223
Valman HB, White DC (1977) Stellate block for quinine blindness in a child. Br Med J 1977:1065
Verpoorte R, Mulder-Krieger Th, Troost JJ, Baerheim Svendsen A (1980) Thin-layer chromatographic separation of cinchona alkaloids. J Chromatogr 184:79–96
Vetter RC (1936) Neuere Probleme der Chininaufbereitung. In: Festschrift E.C. Barell. F. Hoffmann-La Roche, Basel
Warhurst DC, Homewood CA, Peters W, Baggaley YC (1972) Pigment changes in Plasmodium berghei as indicators of activity and mode of action of antimalarial drugs. J Parasitol (Special Issue) 39:271–279
Warhurst DC, Thomas S (1975) Pharmacology of the malaria parasite-a study of dose-response relationships in chloroquine-induced autophagic vacuole formation in Plasmodium berghei. Biochem Pharmacol 24:2047–2056
Watabe T, Kiyonaga K (1972) The metabolic fate of quinine in rabbits. J Pharm Pharmacol 24:625–630
WHO Techn Rpt Series No 529 (1973) Chemotherapy of malaria and resistance to antimalarials. WHO, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hofheinz, W., Merkli, B. (1984). Quinine and Quinine Analogues. In: Peters, W., Richards, W.H.G. (eds) Antimalarial Drug II. Handbook of Experimental Pharmacology, vol 68 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69254-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-69254-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69256-7
Online ISBN: 978-3-642-69254-3
eBook Packages: Springer Book Archive